Walter Miller

Biography

Walter Miller has more than 15 years of experience in the biotech and pharmaceutical industry, in both startups and listed companies. In 2013, he became the authorized signatory and commercial director (CFO) of Nuvisan GmbH, Germany, an international contract research organization (CRO) and laboratory service provider, where he assumed responsibility for the commercial and administrative areas of the company. Prior to this, between 2002 and 2013, he held various management positions in the Santhera Pharmaceuticals Group, initially in Germany and later in Switzerland, most recently as Vice President Finance & Commercial Operations and as a Member of the Executive Board. In particular, his remit included the development of the organization, the accounting system and project controlling as well as handling strategic financial matters and in- and out-licensing activities. Furthermore, he was significantly involved in the cross-border merger, the initial public offering (IPO) on the SIX Swiss Exchange and various financing deals. Before entering the biotech and pharmaceutical industry, Walter Miller’s last position was as Head of Accounting and Controlling at Parsytec AG, Germany. In this role, his responsibility covered the Group’s international consolidated financial statements in accordance with US-GAPP, project controlling and the finances of foreign subsidiaries. In addition, he was on the IPO team in 1999. Walter Miller has more than 15 years of experience in the biotech and pharmaceutical industry, in both startups and listed companies. In 2013, he became the authorized signatory and commercial director (CFO) of Nuvisan GmbH, Germany, an international contract research organization (CRO) and laboratory service provider, where he assumed responsibility for the commercial and administrative areas of the company. Prior to this, between 2002 and 2013, he held various management positions in the Santhera Pharmaceuticals Group, initially in Germany and later in Switzerland, most recently as Vice President Finance & Commercial Operations and as a Member of the Executive Board. In particular, his remit included the development of the organization, the accounting system and project controlling as well as handling strategic financial matters and in- and out-licensing activities. Furthermore, he was significantly involved in the cross-border merger, the initial public offering (IPO) on the SIX Swiss Exchange and various financing deals. Before entering the biotech and pharmaceutical industry, Walter Miller’s last position was as Head of Accounting and Controlling at Parsytec AG, Germany. In this role, his responsibility covered the Group’s international consolidated financial statements in accordance with US-GAPP, project controlling and the finances of foreign subsidiaries. In addition, he was on the IPO team in 1999.

Research Interest

Breast cancer cancer cell studies oncological studies